InnoSkel Awarded Innovation Passport by the UK MHRA for the Treatment of a Rare Bone Disorder

Nice, France, Dec. 16 (Korea Bizwire) – InnoSkel (the “Company”), a pioneering biotechnology company developing transformative therapies for the unmet needs of individuals with rare bone disorders, today announced that it has been awarded an Innovation Passport under the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) Innovative Licensing and Access Pathway (ILAP), to pursue accelerated patient access [...]